forasartan has been researched along with angiotensin ii in 10 studies
Studies (forasartan) | Trials (forasartan) | Recent Studies (post-2010) (forasartan) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
---|---|---|---|---|---|
15 | 1 | 0 | 38,152 | 1,089 | 7,413 |
Protein | Taxonomy | forasartan (IC50) | angiotensin ii (IC50) |
---|---|---|---|
Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (60.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anzini, M; Cappelli, A; De Benedetti, PG; Ferrari, F; Gallelli, A; Giorgi, G; Makovec, F; Mennuni, L; Menziani, MC; Pericot Mohr Gl, Gl; Rizzo, M; Vomero, S | 1 |
Bittner, SE; Brown, MA; Chen, ST; Corpus, VM; McGraw, DE; McMahon, EG; Null, CL; Olins, GM; Palomo, MA; Smits, GJ | 1 |
Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Ohta, K; Takaori, K; Yukimura, T | 1 |
Furukawa, T; Usune, S | 1 |
Brunner, HR; Burns, TS; Hagmann, M; Karim, A; Naudin, RB; Nussberger, J; Waeber, B | 1 |
Babler, MA; Cook, CS; McMahon, EG; Olins, GM; Palomo, MA; Suleymanov, OD; Yang, PC | 1 |
Abe, Y; Aki, Y; Kimura, S; Kiyomoto, K; Nishiyama, A; Tomohiro, A | 1 |
Furukawa, T; Katsuragi, T; Kushiku, K; Shibata, K; Tokunaga, R; Yamada, H | 1 |
Guangyuan, L; Honda, K; Katsuragi, T; Sato, C | 1 |
Krovat, EM; Langer, T | 1 |
1 trial(s) available for forasartan and angiotensin ii
Article | Year |
---|---|
SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Area Under Curve; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Injections, Intravenous; Male; Pyridines; Radioimmunoassay; Renin; Single-Blind Method; Tetrazoles; Vasoconstrictor Agents | 1997 |
9 other study(ies) available for forasartan and angiotensin ii
Article | Year |
---|---|
Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Thoracic; Binding, Competitive; Computer Simulation; Crystallography, X-Ray; Drug Design; Imidazoles; In Vitro Techniques; Isometric Contraction; Ligands; Liver; Male; Models, Molecular; Molecular Structure; Muscle, Smooth, Vascular; Purines; Pyridines; Quinolines; Rabbits; Radioligand Assay; Rats; Rats, Wistar; Structure-Activity Relationship; Tetrazoles | 2004 |
Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
Topics: Administration, Oral; Adrenal Cortex; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Blood Pressure; Female; Heart Rate; Hypertension; In Vitro Techniques; Male; Muscle, Smooth; Peptidyl-Dipeptidase A; Pyridines; Rabbits; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Renin; Tetrazoles; Uterus | 1993 |
Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Blotting, Northern; Captopril; Collagen; Extracellular Matrix; Gene Expression Regulation; Heart Ventricles; Hypertension; Male; Organ Size; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1994 |
Effects of SC-52458, a new nonpeptide angiotensin II receptor antagonist, on increase in cytoplasmic Ca2+ concentrations and contraction induced by angiotensin II and K(+)-depolarization in guinea-pig taenia coli.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atropine; Calcium; Colon; Cytoplasm; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neuromuscular Depolarizing Agents; Parasympatholytics; Potassium; Pyridines; Tetrazoles; Tetrodotoxin | 1996 |
Effects of SC-52458, an angiotensin AT1 receptor antagonist, in the dog.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Hypertension, Renovascular; Pyridines; Rabbits; Rats; Tetrazoles | 1997 |
The role of basally synthesized nitric oxide in modulating the renal vasoconstrictor action of angiotensin II.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arginine; Dogs; Enzyme Inhibitors; Female; Kidney; Male; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Phenylephrine; Pyridines; Renal Artery; Renal Circulation; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Upregulation of immunoreactive angiotensin II release and angiotensinogen mRNA expression by high-frequency preganglionic stimulation at the canine cardiac sympathetic ganglia.
Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Atropine; Blotting, Northern; Captopril; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Ganglia, Sympathetic; Gene Expression Regulation; Heart; Heart Rate; Pentolinium Tartrate; Pyridines; RNA, Messenger; Stellate Ganglion; Tetrazoles; Tissue Distribution; Up-Regulation | 2001 |
Inositol(1,4,5)trisphosphate signal triggers a receptor-mediated ATP release.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Calcium Channels; Calcium Signaling; Cell Line; Cells, Cultured; Colon; Guinea Pigs; Humans; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Muscle, Smooth; Pyridines; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; Tetrazoles | 2002 |
Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
Topics: Acrylates; Algorithms; Angiotensin II; Biphenyl Compounds; Databases, Factual; Imidazoles; Lactones; Losartan; Models, Molecular; Molecular Conformation; Pyridines; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfones; Tetrazoles; Thiophenes | 2003 |